US Patent 7230032 Calcium blockers to treat proliferative vitreoretinopathy
Patent 7230032 was granted and assigned to Allergan, Inc. on June, 2007 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 12, 2003
0
Date of Patent
June 12, 2007
0
Patent Application Number
10436902
0
Patent Inventor Names
Evan B. Dreyer
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7230032 Calcium blockers to treat proliferative vitreoretinopathy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.